Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformi...
Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea
About this item
Full title
Author / Creator
Publisher
United States: EM Inc USA
Journal title
Language
English
Formats
Publication information
Publisher
United States: EM Inc USA
Subjects
More information
Scope and Contents
Contents
Background: Many patients with type 2 diabetes mellitus (DM) with inadequate long-term blood glucose control with sulfonylurea or metformin monotherapy require additional treatment. The synergistic effects of combining glipizide with metformin on glucose control may be realized by treating the primary effects of type 2 DM, impaired insulin secretio...
Alternative Titles
Full title
Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_73443547
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_73443547
Other Identifiers
ISSN
0149-2918
E-ISSN
1879-114X
DOI
10.1016/S0149-2918(03)80112-1
